LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Penumbra Inc

Chiusa

SettoreSettore sanitario

320.7 0.4

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

319.37

Massimo

321.56

Metriche Chiave

By Trading Economics

Entrata

163M

33M

Vendite

-11M

375M

P/E

Media del settore

73.491

49.888

EPS

0.82

Margine di Profitto

8.695

Dipendenti

4,700

EBITDA

-30M

38M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+12.17% upside

Dividendi

By Dow Jones

Utili prossimi

28 lug 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-224M

13B

Apertura precedente

320.3

Chiusura precedente

320.7

Notizie sul Sentiment di mercato

By Acuity

50%

50%

154 / 344 Classifica in Healthcare

Penumbra Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 gen 2026, 13:29 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 gen 2026, 12:35 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 gen 2026, 12:29 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

6 mag 2026, 20:15 UTC

Utili

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6 mag 2026, 20:07 UTC

Utili

Penumbra 1Q Rev $374.8M >PEN

6 mag 2026, 20:07 UTC

Utili

Penumbra 1Q EPS 82c >PEN

25 feb 2026, 18:02 UTC

Utili

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

25 feb 2026, 18:01 UTC

Utili

Penumbra 4Q Rev $385.4M >PEN

25 feb 2026, 18:01 UTC

Utili

Penumbra 4Q Adj EPS $1.18 >PEN

25 feb 2026, 18:01 UTC

Utili

Penumbra 4Q EPS $1.20 >PEN

24 gen 2026, 06:18 UTC

Acquisizioni, Fusioni, Takeovers

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

15 gen 2026, 14:37 UTC

Azioni calde

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 gen 2026, 13:45 UTC

Acquisizioni, Fusioni, Takeovers

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 gen 2026, 12:04 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 gen 2026, 12:03 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 gen 2026, 12:01 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 gen 2026, 12:00 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 gen 2026, 12:00 UTC

Acquisizioni, Fusioni, Takeovers

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Confronto tra pari

Modifica del prezzo

Penumbra Inc Previsione

Obiettivo di Prezzo

By TipRanks

12.17% in crescita

Previsioni per 12 mesi

Media 358.25 USD  12.17%

Alto 374 USD

Basso 335 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Penumbra Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

1

Acquista

3

Mantieni

0

Vendi

Sentiment

By Acuity

154 / 344 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat